Advances in targeting the WNT/13-catenin signaling pathway in cancer

被引:84
作者
Chatterjee, Avradip [1 ]
Paul, Sayan [2 ,6 ]
Bisht, Bharti [3 ]
Bhattacharya, Shelley [4 ]
Sivasubramaniam, Sudhakar [2 ]
Paul, Manash K. [5 ]
机构
[1] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA
[2] Manonmaniam Sundaranar Univ, Dept Biotechnol, Tirunelveli 627012, Tamil Nadu, India
[3] Univ Calif Los Angeles, Dept Thorac Surg, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Visva Bharati, Dept Zool, Environm Toxicol Lab, Ctr Adv Studies, Santini Ketan 731235, W Bengal, India
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pulm & Crit Care Med, Los Angeles, CA 90095 USA
[6] Inst Stem Cell Sci & Regenerat Med InStem, Ctr Cardiovasc Biol & Dis, Bangalore 560065, Karnataka, India
关键词
WNT; b-catenin signaling; Cancer; Inhibitors; Protein-small molecule interaction; Natural products; Drug design; Phase transition; Phosphorylation; Nuclear transport; Clinical trials; Artificial intelligence; Targeting protein-protein interaction; Challenges; SMALL-MOLECULE INHIBITORS; CATENIN NUCLEAR TRANSPORT; DISHEVELLED PDZ DOMAIN; SILICO DRUG DISCOVERY; BETA-CATENIN; CRYSTAL-STRUCTURE; URSOLIC ACID; BINDING; CELLS; AXIN;
D O I
10.1016/j.drudis.2021.07.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
WNT/b-catenin signaling orchestrates various physiological processes, including embryonic development, growth, tissue homeostasis, and regeneration. Abnormal WNT/b-catenin signaling is associated with various cancers and its inhibition has shown effective antitumor responses. In this review, we discuss the pathway, potential targets for the development of WNT/b-catenin inhibitors, available inhibitors, and their specific molecular interactions with the target proteins. We also discuss inhibitors that are in clinical trials and describe potential new avenues for therapeutically targeting the WNT/b-catenin pathway. Furthermore, we introduce emerging strategies, including artificial intelligence (AI)-assisted tools and technology based actionable approaches, to translate WNT/b-catenin inhibitors to the clinic for cancer therapy.
引用
收藏
页码:82 / 101
页数:20
相关论文
共 122 条
[31]   Multiple functions of the noncanonical Wnt pathway [J].
Gomez-Orte, Eva ;
Saenz-Narciso, Beatriz ;
Moreno, Sergio ;
Cabello, Juan .
TRENDS IN GENETICS, 2013, 29 (09) :545-553
[32]   An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway [J].
Gonsalves, Foster C. ;
Klein, Keren ;
Carson, Brittany B. ;
Katz, Shauna ;
Ekas, Laura A. ;
Evans, Steve ;
Nagourney, Robert ;
Cardozo, Timothy ;
Brown, Anthony M. C. ;
DasGupta, Ramanuj .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (15) :5954-5963
[33]   Crystal structure of a β-catenin/Tcf complex [J].
Graham, TA ;
Weaver, C ;
Mao, F ;
Kimelman, D ;
Xu, WQ .
CELL, 2000, 103 (06) :885-896
[34]   Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled [J].
Grandy, David ;
Shan, Jufang ;
Zhang, Xinxin ;
Rao, Sujata ;
Akunuru, Shailaja ;
Li, Hongyan ;
Zhang, Yanhui ;
Alpatov, Ivan ;
Zhang, Xin A. ;
Lang, Richard A. ;
Shi, De-Li ;
Zheng, Jie J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (24) :16256-16263
[35]   RAPGEF5 Regulates Nuclear Translocation of β-Catenin [J].
Griffin, John N. ;
del Viso, Florencia ;
Duncan, Anna R. ;
Robson, Andrew ;
Hwang, Woong ;
Kulkarni, Saurabh ;
Liu, Karen J. ;
Khokha, Mustafa K. .
DEVELOPMENTAL CELL, 2018, 44 (02) :248-+
[36]   Development and structural analysis of adenosine site binding tankyrase inhibitors [J].
Haikarainen, Teemu ;
Waaler, Jo ;
Ignatev, Alexander ;
Nkizinkiko, Yves ;
Venkannagari, Harikanth ;
Obaji, Ezeogo ;
Krauss, Stefan ;
Lehtio, Lari .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (02) :328-333
[37]   Tankyrases: Structure, Function and Therapeutic Implications in Cancer [J].
Haikarainen, Teemu ;
Krauss, Stefan ;
Lehtio, Lari .
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (41) :6472-6488
[38]   Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics [J].
Harb, Jerry ;
Lin, Pen-Jen ;
Hao, Jijun .
CURRENT ONCOLOGY REPORTS, 2019, 21 (02)
[39]   β-Catenin-SOX2 signaling regulates the fate of developing airway epithelium [J].
Hashimoto, Shuichi ;
Chen, Huaiyong ;
Que, Jianwen ;
Brockway, Brian L. ;
Drake, Jeffrey A. ;
Snyder, Joshua C. ;
Randell, Scott H. ;
Stripp, Barry R. .
JOURNAL OF CELL SCIENCE, 2012, 125 (04) :932-942
[40]   Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer [J].
He, Bai-Cheng ;
Gao, Jian-Li ;
Zhang, Bing-Qiang ;
Luo, Qing ;
Shi, Qiong ;
Kim, Stephanie H. ;
Huang, Enyi ;
Gao, Yanhong ;
Yang, Ke ;
Wagner, Eric R. ;
Wang, Linyuan ;
Tang, Ni ;
Luo, Jinyong ;
Liu, Xing ;
Li, Mi ;
Bi, Yang ;
Shen, Jikun ;
Luther, Gaurav ;
Hu, Ning ;
Zhou, Qixin ;
Luu, Hue H. ;
Haydon, Rex C. ;
Zhao, Yingming ;
He, Tong-Chuan .
MOLECULAR PHARMACOLOGY, 2011, 79 (02) :211-219